BACKGROUND: The objective of this study was to investigate the relationships between genotypes of delta-aminolevulinic acid (ALA) dehydratase (ALAD) and disturbances in the heme biosynthetic pathway by lead exposure. METHODS: The subjects were 192 male lead workers and 125 control subjects. Blood lead concentrations (Pb-B), plasma ALA concentrations (ALA-P), and ALAD genotypes were determined for all subjects. In lead workers, ALAD activity, ALA in urine (ALA-U), and erythrocyte zinc protoporphyrin (ZP) were also determined. RESULTS: The frequency of ALAD2 (minor type of ALAD allele) was calculated to be 0.087 in all subjects. No significant relationship was found between ALAD2 frequency and Pb-B levels in lead workers. ALAD1 homozygotes showed significantly higher levels of ZP and ALA-P in comparison with those of ALAD2 carriers at Pb-B levels more than 20 microg/dL and 40 microg/dL, respectively. CONCLUSIONS: ALAD1 homozygotes might be more susceptible than ALAD2 carriers to disturbances in heme metabolism caused by lead exposure. Copyright 2000 Wiley-Liss, Inc.
BACKGROUND: The objective of this study was to investigate the relationships between genotypes of delta-aminolevulinic acid (ALA) dehydratase (ALAD) and disturbances in the heme biosynthetic pathway by lead exposure. METHODS: The subjects were 192 male lead workers and 125 control subjects. Blood lead concentrations (Pb-B), plasma ALA concentrations (ALA-P), and ALAD genotypes were determined for all subjects. In lead workers, ALAD activity, ALA in urine (ALA-U), and erythrocyte zinc protoporphyrin (ZP) were also determined. RESULTS: The frequency of ALAD2 (minor type of ALAD allele) was calculated to be 0.087 in all subjects. No significant relationship was found between ALAD2 frequency and Pb-B levels in lead workers. ALAD1 homozygotes showed significantly higher levels of ZP and ALA-P in comparison with those of ALAD2 carriers at Pb-B levels more than 20 microg/dL and 40 microg/dL, respectively. CONCLUSIONS: ALAD1 homozygotes might be more susceptible than ALAD2 carriers to disturbances in heme metabolism caused by lead exposure. Copyright 2000 Wiley-Liss, Inc.
Authors: Andrew Taylor; Jurgen Angerer; Josiane Arnaud; Françoise Claeys; Jesper Kristiansen; Olav Mazarrasa; Antonio Menditto; Marina Patriarca; Alain Pineau; Sinikka Valkonen; Cas Weykamp Journal: Int Arch Occup Environ Health Date: 2006-06-03 Impact factor: 3.015
Authors: J Weuve; K T Kelsey; J Schwartz; D Bellinger; R O Wright; P Rajan; A Spiro; D Sparrow; A Aro; H Hu Journal: Occup Environ Med Date: 2006-06-06 Impact factor: 4.402
Authors: Natalia Felitsyn; Colin McLeod; Albert L Shroads; Peter W Stacpoole; Lucia Notterpek Journal: J Neurochem Date: 2008-07-04 Impact factor: 5.372
Authors: A M O'Halloran; C C Patterson; P Horan; A Maree; R Curtin; A Stanton; P P McKeown; D C Shields Journal: J Thromb Thrombolysis Date: 2008-02-08 Impact factor: 2.300
Authors: Franco Scinicariello; H Edward Murray; Daphne B Moffett; Henry G Abadin; Mary J Sexton; Bruce A Fowler Journal: Environ Health Perspect Date: 2007-01 Impact factor: 9.031